SCOPUS 정보 검색 플랫폼

Volumn 81, Issue 21, 2013, Pages 1808-1809

Fibroblast growth factor 21, a biomarker for mitochondrial muscle disease

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 21;

DISORDERS OF MITOCHONDRIAL FUNCTIONS; EDITORIAL; HUMAN; MUSCLE DISEASE; MUSCLE WEAKNESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; MALE; MITOCHONDRIAL DISEASES; MUSCULAR DISEASES;

EID: 84891922562 PISSN: 00283878 EISSN: 1526632X Source Type: Journal
DOI: 10.1212/01.wnl.0000436076.06159.2c Document Type: Editorial

Times cited : (3)

References (9)

1
- 77957743736
- Mitochondrial myopathy induces a starvation-like response
- Tyynismaa H, Carroll CJ, Raimundo N, et al. Mitochondrial myopathy induces a starvation-like response. Hum Mol Genet 2010;19:3948-3958.
- (2010) Hum Mol Genet , vol.19 , pp. 3948-3958
- Tyynismaa, H.¹ Carroll, C.J.² Raimundo, N.³

2
- 54849438574
- FGF21 is an Akt-regulated myokine
- Izumiya Y, Bina HA, Ouchi N, Akasaki Y, Kharitonenkov A, Walsh K. FGF21 is an Akt-regulated myokine. FEBS Lett 2008;582:3805-3810.
- (2008) FEBS Lett , vol.582 , pp. 3805-3810
- Izumiya, Y.¹ Bina, H.A.² Ouchi, N.³ Akasaki, Y.⁴ Kharitonenkov, A.⁵ Walsh, K.⁶

3
- 34249711964
- Hepatic fibroblast growth factor 21 is regulated by PPARa and is a key mediator of hepatic lipid metabolism in ketotic states
- Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E. Hepatic fibroblast growth factor 21 is regulated by PPARa and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab 2007;5:426-437.
- (2007) Cell Metab , vol.5 , pp. 426-437
- Badman, M.K.¹ Pissios, P.² Kennedy, A.R.³ Koukos, G.⁴ Flier, J.S.⁵ Maratos-Flier, E.⁶

4
- 79957992155
- Human HMGCS2 regulates mitochondrial fatty acid oxidation and FGF21 expression in HepG2 cell line
- Vilà-Brau A, De Sousa-Coelho AL, Mayordomo C, Haro D, Marrero PF. Human HMGCS2 regulates mitochondrial fatty acid oxidation and FGF21 expression in HepG2 cell line. J Biol Chem 2011;286:20423-20430.
- (2011) J Biol Chem , vol.286 , pp. 20423-20430
- Vilà-Brau, A.¹ De Sousa-Coelho, A.L.² Mayordomo, C.³ Haro, D.⁴ Marrero, P.F.⁵

5
- 80051667626
- FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: A diagnostic study
- Suomalainen A, Elo JM, Pietiläinen KH, et al. FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. Lancet Neurol 2011; 10:806-818.
- (2011) Lancet Neurol , vol.10 , pp. 806-818
- Suomalainen, A.¹ Elo, J.M.² Pietiläinen, K.H.³

6
- 84891909814
- Fibroblast growth factor 21 is a sensitive biomarker of mitochondrial disease
- Davis RL, Liang C, Edema-Hildebrand F, Riley C, Needham M, Sue CM. Fibroblast growth factor 21 is a sensitive biomarker of mitochondrial disease. Neurology 2013;81:1819-1826.
- (2013) Neurology , vol.81 , pp. 1819-1826
- Davis, R.L.¹ Liang, C.² Edema-Hildebrand, F.³ Riley, C.⁴ Needham, M.⁵ Sue, C.M.⁶

7
- 20444435873
- FGF-21 as a novel metabolic regulator
- Kharitonenkov A, Shiyanova TL, Koester A, et al. FGF-21 as a novel metabolic regulator. J Clin Invest 2005;115:1627-1635.
- (2005) J Clin Invest , vol.115 , pp. 1627-1635
- Kharitonenkov, A.¹ Shiyanova, T.L.² Koester, A.³

8
- 84872057896
- Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine
- Kim KH, Jeong YT, Oh H, et al. Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine. Nat Med 2013;19:83-92.
- (2013) Nat Med , vol.19 , pp. 83-92
- Kim, K.H.¹ Jeong, Y.T.² Oh, H.³

9
- 84856092782
- Effect of bezafibrate treatment on late-onset mitochondrial myopathy in mice
- Yatsuga S, Suomalainen A. Effect of bezafibrate treatment on late-onset mitochondrial myopathy in mice. Hum Mol Genet 2012;21:526-535.
- (2012) Hum Mol Genet , vol.21 , pp. 526-535
- Yatsuga, S.¹ Suomalainen, A.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.